NBY - NovaBay Pharmaceuticals, Inc.
0.564
-0.006 -1.099%
Share volume: 87,946
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.57
-0.01
-0.01%
View ratios
| Fiscal Date | 09-30-2024 | |
|---|---|---|
| Fiscal Quarter | Q3 2024 | |
| Report Date | 11-07-2024 | |
| Assets | ||
| Total Assets | 3.877 M | |
| Current Assets | 2.279 M | |
| Inventories | 473.000 K | |
| Other Current Assets | 0.000 | |
| Short Term Investments | 0.000 | |
| Total Receivables | 0.000 | |
| Current Cash | 776.000 K | |
| Total Non-current Assets | 0.000 | |
| Property Plant Equipment | 61.000 K | |
| Other Assets | 1.537 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 3.877 M | |
| Total liabilities | 2.805 M | |
| Total current liabilities | 1.984 M | |
| Accounts Payable | 396.000 K | |
| Other liabilities | 0.000 | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 0.000 | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 1.066 M | |
| Common stock | 183.311 M | |
| Retained earnings | -182.245 M |
